BioCentury
ARTICLE | Company News

Cloud Pharmaceuticals, Therametrics deal

November 2, 2015 8:00 AM UTC

Cloud and Therametrics partnered to discover, develop and commercialize small molecule and peptide therapeutics for Orphan central nervous system (CNS) diseases and other indications. The partners wil...